Delivery Order SPE2DB20D3103-SPE2DB23FN0T2
Award Date 4/13/23
Potential Completion Date 4/14/23
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,469.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,983,231 units of Citalopram HBR 40 mg tablets, a pharmaceutical product, with a completion date of May 19, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,586,690 tablets of Citalopram HBR 40 mg. The $60,158.76 firm fixed-price contract has an ultimate completion date of October 25, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
- This federal contract award, valued at $6,241.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 MG Tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- This federal contract award is for the delivery of citalopram HBR 40 mg tablets in quantities of 500 to the Defense Logistics Agency (DLA). The contract, valued at $1,201.28, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,756,354 units of Citalopram HBR 40 mg tablets. The Firm Fixed Price delivery order, valued at $1,997.07, has an ultimate completion date of August 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The contract award is not...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D1100|SPE2DB24FZ46Z) from the Defense Logistics Agency (DLA) Troop Support Medical. The $14,876.66 firm fixed-price contract is for the delivery of 4563189362 units of Citalopram HBR 40 mg tablets, with a completion date of December 28, 2023. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly...
- This federal contract award, valued at $1,879.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,471 units of the pharmaceutical drug Citalopram HBR 40 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 30, 2024. This contract award is not designated as a set-aside and was issued through full and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Citalopram HBR 40 mg tablets. The $9,423.28 Firm Fixed Price Delivery Order has an ultimate completion date of July 12, 2024. This order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies...
- This federal contract award, valued at $3,818.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,841,042 units of the pharmaceutical Citalopram HBR 40 mg tablets, with a completion date of November 17, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...